Endoscopic ultrasonography features of gastric mucosal cobblestone-like changes from a proton-pump inhibitor

Clin J Gastroenterol. 2017 Jun;10(3):220-223. doi: 10.1007/s12328-017-0724-5. Epub 2017 Mar 6.

Abstract

A 68-year-old man with no symptoms presented to Hokkaido University Hospital for esophagogastroduodenoscopy screening. He had a history of Helicobacter pylori eradication. Initial esophagogastroduodenoscopy showed no gastric cobblestone-like mucosa or gastric cracked mucosa. After 1 year, he received esomeprazole (20 mg) once daily for heartburn at another hospital. Esophagogastroduodenoscopy was performed after 2 years of esomeprazole administration. Endoscopic findings showed that after H. pylori eradication, according to the Kyoto classification, gastric cobblestone-like mucosa presented in the gastric body area. Dilation of the oval crypt opening and intervening part in the gastric cobblestone-like mucosa was detected by endoscopy with narrow band imaging. Endoscopic ultrasonography revealed a thick gastric second layer and sporadic small a-echoic lesions in the low-echoic thickened second layer in the gastric cobblestone-like mucosa. The gastric cobblestone-like mucosa biopsy specimen showed parietal cell protrusions and oxyntic gland dilatations. Recently, we reported that gastric mucosal changes such as gastric cracked mucosa and gastric cobblestone-like mucosa were caused by proton-pump inhibitors; however, the gastric cobblestone-like mucosa was not examined by endoscopic ultrasonography. In this case, endoscopic ultrasonography findings suggested that oxyntic gland dilatations caused the elevated gastric mucosa, such as gastric cobblestone-like mucosa, from the use of proton-pump inhibitors.

Keywords: Cobblestone-like changes; Endoscopic ultrasonography; Proton-pump inhibitor.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Endosonography
  • Esomeprazole / adverse effects*
  • Esomeprazole / therapeutic use
  • Gastric Mucosa / diagnostic imaging
  • Gastric Mucosa / drug effects*
  • Gastric Mucosa / pathology
  • Heartburn / drug therapy
  • Humans
  • Male
  • Proton Pump Inhibitors / adverse effects*
  • Proton Pump Inhibitors / therapeutic use

Substances

  • Proton Pump Inhibitors
  • Esomeprazole